ΔΎΉΟΦ±²₯

Endocrinology

Metabolic Syndrome

More in Metabolic Syndrome

Meat Types and T2D; Semaglutide in Heart Failure; Acromegaly at the Paralympics

News and commentary from the endocrinology world

Sep 03, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
T1D Stem Cell Success Story; Lilly's Discount Tirzepatide Vials; Stelo Now Available

News and commentary from the endocrinology world

Aug 27, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
Zepbound Can Prevent Diabetes; Menopause and Cognition; Tandem's Insulin Pump Update

News and commentary from the endocrinology world

Aug 20, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
Disposable CGM Approved; Mounjaro Tied to Reduced Mortality; Benefits of Lignins

News and commentary from the endocrinology world

Aug 13, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
Eating Disorders After GLP-1s? Tirzepatide for Heart Failure; Soda Taxes and BMI

News and commentary from the endocrinology world

Aug 06, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
Faulty FreeStyle Libre 3 Sensors; Endocrine Society Merger; More Levemir Pushback

News and commentary from the endocrinology world

Jul 30, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
Early-Stage GLP-1 Win in Obesity; An Argument for BMI's Value; Insulin Supply Issues

News and commentary from the endocrinology world

Jul 23, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
People Without Diabetes Make Up Growing Share of GLP-1 Users

Approximately one-fourth of new users in 2023 did not have type 2 diabetes

Jul 22, 2024
A photo of a woman holding two injection pens.
Few Stick With Ozempic; Pfizer Making Daily GLP-1; Once-Weekly Insulin Turned Down

News and commentary from the endocrinology world

Jul 16, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
New Investigational Fertility Pill; Biden Wants Lower GLP-1 Prices; BVO to Be Banned

News and commentary from the endocrinology world

Jul 09, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
Tirzepatide Bests Semaglutide for Real-World Weight Loss

Injectables were compared at doses approved for type 2 diabetes

Jul 08, 2024
A photo of a box of Mounjaro injection pens.
CAH Drug Under Review; Gender-Affirming Surgery in Kids; CGMs for Non-Diabetics

News and commentary from the endocrinology world

Jul 01, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
First GLP-1 Generic Launched; 5:2 Intermittent Fasting Win; WHO's Ozempic Warning

News and commentary from the endocrinology world

Jun 25, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
Novel Triple-Hormone Agonist Boosts Beta-Cell Function in T2D

Insulin sensitivity also improved in people with obesity free of diabetes

Jun 23, 2024
ADA over a photo of Orange County Convention Center in Orlando, FL
More in Metabolic Syndrome

0.75 CME Credits
Navigating Endocrine Resistance: Latest Strategies in HR+/HER2- Breast Cancer Care

1.00 CME Credits
Navigating Cardiovascular Risk: The Critical Role of Lipoprotein(a) Screening and Treatment

0.50 CME Credits
Breakthroughs in Severe Hypertriglyceridemia and Familial Chylomicronemia Syndrome Management: Key Findings From ACC 2024

0.50 CME Credits
Adjuvant Endocrine Therapy in HR+ Breast Cancer: Enhancing Quality Care and Patient Outcomes

1.00 CME Credits
Evidence-Based Strategies and Emerging Approaches for Individualizing Obesity Care

0.25 CME Credits
Applying the Latest Evidence to Overcome Endocrine Resistance in HR+/HER2- Breast Cancer

1.00 CME Credits
Leveraging Continuous Glucose Monitoring (CGM) to Improve Outcomes in Type 2 Diabetes

1.50 CME Credits
Breaking Barriers in Obesity Management: Adopting a Holistic Approach to Optimize Health Outcomes